CMPI.org
MENU
CMPI
Drugwonks

Donors

At the Center for Medicine in the Public Interest, we acknowledge the generosity of our donors and their dedication to our mission and the advancement of healthcare policy.

AbbVie Inc.

Amicus Therapeutics

APCO Worldwide

Aprecia Pharmaceuticals

BIO

Bristol Myers Squibb

ChromaDex

Ewing Marion Kauffman Foundation 

Gilead Sciences, Inc.

GSK

Juul Labs

The Lilly Foundation 

Merck & Co.

National Community Pharmacists Association

Novo Nordisk Inc.

Pfizer, Inc.

PhRMA

Sarepta Therapeutics

Searle Freedom Trust

Stand Together Trust

Standup4Nurses
 
Sign Up for Our Email Newsletter

RECENT NEWS

New JCI Viewpoint: FDA Must Rethink How It Evaluates Precision Medicines for Rare Diseases

New JCI Viewpoint: FDA Must Rethink How It Evaluates Precision Medicines for Rare Diseases

Authors argue that rare disease innovation requires learning more from fewer patients—not enrolling more patients...  Read more

Troubling Trends: Systemic Practices in Texas' Non-Profit Hospitals That Inflate Health Care Costs

Troubling Trends: Systemic Practices in Texas' Non-Profit Hospitals That Inflate Health Care Costs

Texas has an opportunity to lead rather than react. Better measurement would strengthen public confidence without diminis...  Read more

PROTECTING THE U.S. PHARMACEUTICAL SUPPLY CHAIN: A PATH FORWARD

PROTECTING THE U.S. PHARMACEUTICAL SUPPLY CHAIN: A PATH FORWARD

How proactive FDA policies can help strengthen the American pharmaceutical supply chain of essential medicines, create jo...  Read more

Read all News

DRUGWONKS BLOG

RESEARCH ISSUES

Biosimilars
Cure Strategy
Opioids
Personalized Medicine
Price Controls
Safe Drug Use
Tabloid Medicine
The Truth about Drug Pricing
Value of Medical Innovation
Value-Based Reimbursement